Skip to main content
Caplight Logo









Wellgrow Technology

Wellgrow Technology

Private
ShenzhenHealthcare & Life Scienceshttps://wellgrowtec.com/

Last Round

Series B

Extension

Jan 25, 2022

Total Funding Raised

$17M

Company Overview

Wellgrow Technology is a life sciences company that develops in vitro diagnostic medical equipment and reagents for clinical medical diagnostics and food safety.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

in vitro diagnosticsIVDclinical diagnostic equipmentdiagnostic reagentslaboratory automationlab automationimmunofluorescenceflow cytometrydiagnostic testing kitssperm function detectionencoded microspheresclinical lab workflowmedical device manufacturerautomated sample loadingbiotech equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wellgrow Technology Comparables

Compare Wellgrow Technology with similar companies based on industry and business-model similarity.

Wellgrow Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Guangzhou Weimi Bio-Tech Co., Ltd.
87%
Hubei NewZongke Viral Disease Control Bio-Tech Ltd.
87%
Beadstar Biotechnology (Hainan) Co., Ltd.
79%

Wellgrow Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionJan 25, 2022
Series BJun 1, 2021
Series AJan 2, 2020
AngelDec 1, 2017

Wellgrow Technology Investors

Notable investors and investment history

Wellgrow Technology investors
InvestorRounds
YuanBio Venture CapitalSeries B
Vinno CapitalSeries A, Series B, Angel
China Merchants HealthSeries B Extension
Share CapitalAngel
松禾资本 (Green Pine Capital Partners)Series A
Cowin CapitalSeries B Extension, Series B
Bin Yuan CapitalSeries B Extension, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 25, 2022

    Led by China Merchants Health with participation from Bin Yuan Capital and Cowin Capital.

  • Jun 1, 2021

    $16M round led by Bin Yuan Capital

Wellgrow Technology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Wellgrow Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Wellgrow Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersShenzhen
Employee Range2
Year FoundedN/A
Last FundingJan 25, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?